"CTIX is pleased to announce conclusion of the last patient visit in its randomized, double-blind Phase 2 trial of orally-administered Prurisol for the treatment of mild to mid-stage plaque psoriasis. The unblinding of the study and top-line data is expected to be available in May... THERE WERE NO SAFETY ITEMS OF CONCERN."

haven't gotten email with link from the company yet. I think they are avoiding any appearance of impropriety, making sure it hits the wires before we get emails.